[Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration?].
Aguilar
L
L
Departamento de Microbiología, Facultad de Medicina, Universidad Complutense, Madrid.
Giménez
M J
MJ
Martín
J E
JE
Prieto
J
J
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002442:Ceftazidime / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006801:Humans; D007262:Infusions, Intravenous; D011552:Pseudomonas Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D002442:Ceftazidime